Symptom Experience of Lung Cancer Patients Treated With Immunotherapy Combined With Chemotherapy: A Longitudinal Study
May 2025
in “
Life Studies
”
Studysummary In this study, lung cancer patients undergoing treatment with immune checkpoint inhibitors and chemotherapy reported high incidence and severity of symptoms such as fatigue, drowsiness, and loss of appetite, which were most prominent and distressing throughout the treatment cycles.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on ls.cscholar.com →